Teeft.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Teeft.i » - entrée « Influenza virus infection »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Influenza virus host resistance < Influenza virus infection < Influenza virus infections  Facettes :

List of bibliographic references indexed by Influenza virus infection

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000B09 (2012) Enguang Feng [République populaire de Chine] ; Deju Ye [République populaire de Chine] ; Jian Li [République populaire de Chine] ; Dengyou Zhang [République populaire de Chine] ; Jinfang Wang [République populaire de Chine] ; Fei Zhao [République populaire de Chine] ; Rolf Hilgenfeld [République populaire de Chine, Allemagne] ; Mingyue Zheng [République populaire de Chine] ; Hualiang Jiang [République populaire de Chine] ; Hong Liu [République populaire de Chine]Recent Advances in Neuraminidase Inhibitor Development as Anti‐influenza Drugs
000F34 (2010) Giuseppe Lippi [Italie] ; Mario Plebani [Italie]Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype?
001425 (2007) W S Lim [Royaume-Uni]Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic
001676 (2004) Hiroshi Kido [Japon] ; Yuushi Okumura [Japon] ; Hiroshi Yamada [Japon] ; Dai Mizuno [Japon] ; Youichirou Higashi [Japon] ; Mihiro Yano [Japon]Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
001724 (2003) Susan J. Baigent [Royaume-Uni] ; John W. Mccauley [Royaume-Uni]Influenza type A in humans, mammals and birds: Determinants of virus virulence, host‐range and interspecies transmission
001815 (2001) Kimberly A. Benton [États-Unis] ; Julia A. Misplon [États-Unis] ; Chia-Yun Lo [États-Unis] ; Suzanne L. Epstein [États-Unis]Susceptibility and immunity to influenza A strains in Ig−/−mice
001829 (2001) M. Louise Herlocher [États-Unis] ; Rob Fenton [Royaume-Uni] ; Andrew Merry [États-Unis] ; Stephanie Elias [États-Unis] ; Arnold S. Monto [États-Unis]Influenza resistance to zanamivir generated in ferrets
001918 (2000) Jason K. Whitmire [États-Unis] ; Rafi Ahmed [États-Unis]Costimulation in antiviral immunity: differential requirements for CD4+ and CD8+ T cell responses
001996 (1999) Nancy J. Cox [États-Unis] ; Kanta Subbarao [États-Unis]Influenza
001A46 (1998) John S. Oxford [Royaume-Uni] ; Robert Lambkin [Royaume-Uni]Targeting influenza virus neuraminidase—a new strategy for antiviral therapy
001A69 (1998) Suryaprakash Sambhara [Canada] ; Anjna Kurichh [Canada] ; Renata Miranda [Canada] ; Alan Tamane [Canada] ; Rita Arpino [Canada] ; Olive James [Canada] ; Ursula Mcguinness [Canada] ; Ali Kandil [Canada] ; Brian Underdown [Canada] ; Michel Klein [Canada] ; David Burt [Canada]Enhanced immune responses and resistance against infection in aged mice conferred by Flu-ISCOMs vaccine correlate with up-regulation of costimulatory molecule CD86
001B70 (1997) Walter Gerhard [États-Unis] ; Krystyna Mozdzanowska [États-Unis] ; Michelle Furchner [États-Unis] ; George Washko [États-Unis] ; Krista Maiese [États-Unis]Role of the B‐cell response in recovery of mice from primary influenza virus infection
001B80 (1997) Edwin D. Kilbourne [États-Unis]In pursuit of influenza: Fort monmouth to valhalla (and back)
001B86 (1997) Peter C. Doherty [États-Unis] ; David J. Topham [États-Unis] ; Ralph A. Tripp [États-Unis] ; Rhonda D. Cardin [États-Unis] ; James W. Brooks [États-Unis] ; Philip G. Stevenson [États-Unis]Effector CD4+ and CD8+ T‐cell mechanisms in the control of respiratory virus infections
001C49 (1996) Nicholas A. Meanwell ; Mark KrystalTaking aim at a moving target-inhibitors of influenza virus Part 1 : virus adsorption, entry and uncoating
001C52 (1996) Pedro A. Piedra [États-Unis]Rimantadine: Chemoprophylaxis and treatment
001D39 (1995) John Saunders [Royaume-Uni] ; Janet M. Cameron [Royaume-Uni]Recent developments in the design of antiviral agents
001D79 (1994) John J. Treanor [États-Unis]Viral infections of the respiratory tract: prevention and treatment
001D95 (1994) Mary Harward [États-Unis] ; Christine L. Biedermann [États-Unis] ; Timothy R. S. Harward [États-Unis] ; A. Joseph Layon [États-Unis]Pneumonitis of unclear etiology in the surgical intensive care unit leading to the demise of an elderly, immunocompromised woman
001E01 (1994) Takayuki Nagai [Japon] ; Haruki Yamada [Japon]In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine “Sho-seiryu-to” and its mode of action
001E03 (1994) Shin-Ichi Tamura [Japon] ; Hideki Asanuma [Japon] ; Yuji Ito [Japon] ; Keiko Yoshizawa [Japon] ; Takashi Nagamine [Japon] ; Chikara Aizawa [Japon] ; Takeshi Kurata [Japon]Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Influenza virus infection" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Influenza virus infection" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Influenza virus infection
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021